Stämm

Stämm Biotech specializes in life sciences. During the past two years, Stämm has designed a novel bioproduction system that leverages microfluidics, electroporation and robotics to solve the main constraint of the biotech industry: scaling up. Solving this problem could unlock a $700B market in the next 10 years. Today, after integrating these state-of-the-art technologies, the company is unveiling the future of biomanufacturing. Stämm downsized a whole biotech facility into an all-in-one, plug-n-play desktop unit: the Bioprocessor, which has proven to be at least 70x more productive than traditional bioreactors.